RecruitingNCT07071298
AERA Pediatrics Registry
A Real World, Observational Pediatric Registry of the Acclarent AERA® Eustachian Tube Balloon Dilation System
Sponsor
Integra LifeSciences Corporation
Enrollment
300 participants
Start Date
Jun 17, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
Prospective, multi-center, observational, real-world evidence data collection registry to confirm the continued clinical performance of the AERA® device in pediatric patients
Eligibility
Max Age: 18 Years
Inclusion Criteria3
- Age <18
- Specific indications for ETBD are documented
- ETBD with AERA device attempted-
Exclusion Criteria2
- ETBD with device other than AERA®
- Previous ETBD procedure-
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(6)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07071298